Evidence map›Paper›PMID 30586397›Full record

ArticlePloS one2018

Kidney cancer characteristics and genotype-phenotype-correlations in Birt-Hogg-Dubé syndrome.

Elke C Sattler, Marlene Reithmair, Ortrud K Steinlein

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Folliculin gene-negative Birt-Hogg-Dube syndrome: a case report.Annals of medicine and surgery (2012) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cutaneous Expression of Familial Cancer Syndromes.Acta dermato-venereologica · 2021
    Review
  12. [Cancer-associated genodermatoses].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  13. Article
  14. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  15. Article
  16. Ultra-rare cystic disease.European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  17. Birt-Hogg-Dubé syndrome.European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elke C SattlerDepartment of Dermatology and Allergology, University Hospital, LMU Munich, Munich, Germany.
Marlene ReithmairInstitute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0002-9113-9643
Ortrud K SteinleinInstitute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0003-4311-6276
LMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Birt-Hogg-Dubé syndrome (BHDS) is a genetic tumor syndrome characterized by lung cysts, pneumothorax, fibrofolliculomas and renal cell cancer. The diagnosis of BHDS is usually considered if kidney cancer occurs before age 50 years, is multifocal and/or bilateral or of the oncocytoma/hybrid oncocytoma-chromophobe type. Using a sample of 50 BHDS families with a total of 178 patients we analyzed how many kidney cancer patients fulfilled one or more of these criteria. Furthermore, we addressed the question if genotype-phenotype-correlations exist that can be used for risk stratification. Renal cell cancer occurred in 34/178 (19.1%) patients, and the reported male bias was not observed. Furthermore, most kidney malignancies occurred after the age of 50 years. Thus, the majority of tumors did not show the typical hallmarks of BHDS. A below-average tumor frequency (17.2%) was observed for the known mutational hotspot c.1285delC/dupC that was the cause of BHDS in 24% of families. Unexpected was the high tumor frequency (66.7%) associated with mutation c.887C>G within a single family, a finding that merits further exploration.

Indexed as

Genetic Association StudiesAdultAgedBirt-Hogg-Dube SyndromeCarcinoma, Renal CellFemaleHumansKidney NeoplasmsMaleMiddle AgedMutationPenetranceProto-Oncogene ProteinsRisk AssessmentTumor Suppressor ProteinsFLCN protein, humanProto-Oncogene ProteinsTumor Suppressor Proteins

Identifiers

PMID30586397
PMCPMC6306193
OpenAlexW2906501885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.